US Stock MarketDetailed Quotes
ICAD iCAD Inc
- 2.340
- -0.060-2.50%
Close Nov 13 16:00 ET
- 1.930
- -0.410-17.53%
Post 19:55 ET
62.10MMarket Cap-29250P/E (TTM)
2.420High2.240Low490.46KVolume2.420Open2.400Pre Close1.13MTurnover1.96%Turnover RatioLossP/E (Static)26.54MShares2.65052wk High2.01P/B58.51MFloat Cap1.18052wk Low--Dividend TTM25.01MShs Float33.050Historical High--Div YieldTTM7.50%Amplitude1.050Historical Low2.306Avg Price1Lot Size
About iCAD Inc Company
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Company Profile
SymbolICAD
Company NameiCAD Inc
Listing DateDec 14, 1984
Founded1984
CEOMs. Dana Brown
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address98 Spit Brook Road,Suite 100
CityNashua
ProvinceNew Hampshire
CountryUnited States of America
Zip Code03062
Phone1-603-882-5200
Websitehttp://www.icadmed.com
Company Executives
- Name
- Position
- Salary
- Dana Brown
- Executive Chairman of the Board, President and Chief Executive Officer
- 849.05K
- Jonathan Go
- Chief Technology Officer
- 406.56K
- Eric Lonnqvist
- Chief Financial Officer and Principal Accounting Officer
- 311.38K
- Dr. Hedvig Hricak, M.D.,PhD
- Director
- --
- Michael John Doyle
- Director
- --
- Andrew H. Sassine
- Independent Director
- 86.24K
- Dr. Susan Wood, PhD
- Independent Director
- 90.96K
- Dr. Rakesh Patel, M.D.
- Independent Director
- 82.17K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
